Anvisa orders the seizure of irregularly produced tirzepatide
Anvisa has ordered the seizure of tirzepatide products produced irregularly by El Elyon de Manipulação Ltda in Brazil.
The public health system spends tens of millions of euros on unnecessarily high doses of cancer therapies
Spain's public health system incurs annual expenses of tens of millions of euros on excess doses of popular cancer immunotherapies, as pharmaceutical companies persuade regulatory bodies to standardize treatment based on inflated weight assumptions.